Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02106091
Title Safety Study to Assess AFM11 in Patients With Relapsed and/or Refractory CD19 Positive B-cell NHL
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Affimed GmbH
Indications

B-cell lymphoma

lymphoplasmacytic lymphoma

marginal zone B-cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

mantle cell lymphoma

Therapies

AFM11

Age Groups: adult | senior
Covered Countries USA | DEU

Facility Status City State Zip Country Details
Tufts Medical Center Boston Massachusetts 02111 United States Details
Charles Hospital Prague Prague 11636 Czechia Details
University Hospital of the Saarland Homburg/Saar 66421 Germany Details
University Hospital Kiel 24105 Germany Details
University Medical Center of the Johannes Gutenberg University Mainz Mainz 55131 Germany Details
University Hospital Ulm 89081 Germany Details
University Hospital Wuerzburg 97080 Germany Details
SP ZOZ University Hospital Krakow Krakow 31501 Poland Details
MTZ Clinical Research Warsaw 02106 Poland Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field